Atypical serological profiles in hepatitis B virus infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 4, 2013, Pages 461-476

  Pondé, Robério A A ^a,b,c  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b AC   (Brazil)

^c Central Goiana de Sorologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; COMPLEX FORMATION; CROSS REACTION; DISEASE ASSOCIATION; DNA DETERMINATION; FALSE NEGATIVE RESULT; GENE DELETION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; IMMUNOLOGICAL TOLERANCE; MOLECULAR DYNAMICS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; SERODIAGNOSIS; SEROLOGY; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRUS CARRIER; VIRUS MUTANT; VIRUS REPLICATION; VIRUS TRANSMISSION;

HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; SEROLOGIC TESTS;

EID: 84879459757     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1781-9     Document Type: Review

References (125)

1. Chan HL (2002) Changing scene in hepatitis B serology interpretation. Hosp Med 63(1):16-19
2. Juszczyk J (2000) Clinical course and consequences of hepatitis B infection. Vaccine 18:S23-S25 (Pubitemid 30100459)
3. Jung M-C, Pape GR (2002) Immunology of hepatitis B infection. Lancet Infect Dis 2(1):43-50 (Pubitemid 36109305)
4. Kao JH (2008) Diagnosis of hepatitis B virus infection through serological and virological markers. Expert Rev Gastroenterol Hepatol 2(4):553-562
5. Baumert TF, Thimme R, von Weizsacker F (2007) Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (Pubitemid 46165465)
6. Günther S (2006) Genetic variation in HBV infection: genotypes and mutants. J Clin Virol 36(Suppl 1):S3-S11 (Pubitemid 44026521)
7. Sheldon J, Rodès B, Zoulim F, Bartholomeusz A, Soriano V (2006) Mutations affecting the replication capacity of the hepatitis B virus. J Viral Hepat 13:427-434
8. Pondé RA (2011) The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile. Med Microbiol Immunol 200:13-22
9. Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud J-N, Milich DR (2005) Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 79:3016-3027 (Pubitemid 40270581)
10. Diepolder HM, Jung M-C, Wierenga E, Hoffmann RM, Zachoval R, Gerlach TJ, Scholz S, Heavner G, Riethmüller G, Pape GR (1996) Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro. J Virol 70:7540-7548 (Pubitemid 26339059)
11. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoffmann RM, Eichenlaub D, Frösner G, Will H, Pape GR (1995) Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 69:3358-3368
12. Lee JH, Paglieroni TG, Holland PV, Zeldis JB (1992) Chronic hepatitis B virus infection in an anti-HBc-nonreactive blood donor: variant virus or defective immune response? Hepatology 16(1):24-30
13. Laperche S, Guitton C, Smilovici W, Courouce AM (2001) Blood donors infected with the hepatitis B virus but persistently lacking antibodies to the hepatitis B core antigen. Vox Sang 80:90-94 (Pubitemid 35345778)
14. Ni YH, Hsu HY, Chang MH, Chen DS, Lee CY (1993) Absence or delayed appearance of hepatitis B core antibody in chronic hepatitis B surface antigen carrier children. J Hepatology 17(2):150-154 (Pubitemid 23054479)
15. Milich DR, Chen MK, Hughes JL, Jones JE (1998) The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 160:2013-2021 (Pubitemid 28106492)
16. Wang JS, Chen H, Zhu Q-R (2005) Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol 11(23):3582-3585 (Pubitemid 40903518)
17. Coursaget P, Yvonnet B, Bourdil C, Mevelec MN, Adamowicz P, Barrès JL, Chotard J, N'Doye R, Diop Mar I, Chiron JP (1987) HBsAg positive reactivity in man not due to hepatitis B virus. Lancet 2:1354-1358 (Pubitemid 18007237)
18. Echevarría JM, León P, Domingo CJ, López JA, Echevarría JE, Contreras G, Fuertes A (1991) Characterization of HBV2-like infections in Spain. J Med Virol 33(4):240-247
19. Fiordalisi G, Primi D, Tanzi E, Magni E, Incarbone C, Zanetti AR, Cariani E (1994) Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers. J Med Virol 42(2):109-114 (Pubitemid 24077549)
20. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, Pilli M, Fowler P, Giuberti T, Chisari FV, Fiaccadori F (1991) Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 88:214-222
21. Chevaliez S, Pawlotsky J-M (2008) Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes. Best Pract Res Clin Gastroenterol 22(6):1031-1048
22. Lazizi Y, Dubreuil P, Pillot J (1993) Excess HBcAg in HBc antibody-negative chronic hepatitis B virus carriers. Hepatology 17(6):966-970 (Pubitemid 23187397)
23. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR (1993) The serology of chronic hepatitis B infection revisited. J Clin Invest 91:2586-2595 (Pubitemid 23182513)
24. Bredehorst R, von Wulffen H, Granato C (1985) Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen. J Clin Microbiol 21:593-598 (Pubitemid 15106518)
25. Petit MA, Capel F, Pillot J (1985) Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles. Mol Immunol 22:1279-1287 (Pubitemid 16241142)
26. Möller B, Hopf U, Stemerowicz R, Henze G, Gelderblom H (1989) HBcAg expressed on the surface of circulating Dane particles in patients with hepatitis B virus infection without evidence of anti-HBc formation. Hepatology 10(2):179-185 (Pubitemid 19190208)
27. Melegari M, Jung MC, Schneider R, Santantonio T, Bagnulo S, Luchena N, Pastore G, Pape G, Scaglioni PP, Villa E, Will H (1991) Conserved core protein sequences in hepatitis B virus infected patients without anti-HBc. J Hepatol 13(2):187-191
28. Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science 234(4782):1398-1401 (Pubitemid 17210220)
29. Vanlandschoot P, Cao T, Leroux-Roels G (2003) The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure. Antiviral Res 60:67-74 (Pubitemid 37452448)
30. Pondé RA (2011) The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile". Eur J Clin Microbiol Infect Dis 30:1325-1340
31. Raimondo G, Pollicino T, Cacciola I, Squadrito G (2007) Occult hepatitis B virus infection. J Hepatol 46:160-170 (Pubitemid 44827430)
32. Torbenson M, Thomas DL (2002) Occult hepatitis B. Lancet 2:479-486 (Pubitemid 34826853)
33. Rapicetta M, Ferrari C, Levrero M (2002) Viral determinants and host immune responses in the pathogenesis of HBV infection. J Med Virol 67:454-457 (Pubitemid 34569091)
34. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, Pollicino T (2008) Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 48:743-746
35. Zoulim F (2005) New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol 42:302-308 (Pubitemid 40254242)
36. Caruntu FA, Molagic V (2005) CccDNA persistence during natural evolution of chronic HBV infection. Rom J Gastroenterol 14:373-377 (Pubitemid 43027127)
37. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, Cova L, Chevallier P, Mandrand B, Trépo C (2001) High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 34:447-454 (Pubitemid 32240826)
38. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK (2004) Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterol 127(5):1356-1371 (Pubitemid 39457762)
39. Marusawa H, Uemoto S, Hijikata M, Ueda Y, Tanaka K, Shimotohno K, Chiba T (2000) Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31(2):488-495 (Pubitemid 30078617)
40. Loriot M-A, Marcellin P, Walker F, Boyer N, Degott C, Randrianatoavina I, Benhamou JP, Erlinger S (1997) Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 27:251-258 (Pubitemid 27366203)
41. Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yamamoto K, Omura M, Hikiji K, Kato M (2003) Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 37:1172-1179 (Pubitemid 36538695)
42. Allain JP (2004) Occult hepatitis B virus infection. Transfusion 11(1):18-25
43. Melegari M, Scaglioni PP, Wands JR (1997) The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted. J Virol 7(71):5449-5454 (Pubitemid 27258222)
44. Sengupta S, Rehman S, Durgapal H, Acharya SK, Panda SK (2007) Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection. J Med Virol 79:220-228 (Pubitemid 46213185)
45. Osiowy C (2006) Detection of HBsAg mutants. J Med Virol 78:S48-S51 (Pubitemid 43993465)
46. Coleman PF (2006) Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 12(2):198-203
47. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatol 34(1):194-203 (Pubitemid 32591500)
48. Greub G, Frei PC (2001) Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects. Liver 21:380-383 (Pubitemid 33095040)
49. Greub G, Zysset F, Genton B, Spertini F, Frei PC (2001) Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response. Med Microbiol Immunol 189(3):165-168 (Pubitemid 33726403)
50. Heijtink RA, Schneeberger PM, Postma B, Crombach W (2002) Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/L seroprotection levels unreliable. Vaccine 20(23-24):2899-2905 (Pubitemid 34785959)
51. Milich DR, McLachlan A, Chisari FV, Kent SB, Thorton GB (1986) Immune response to the pre-S1 region of the hepatitis B surface antigen (HBsAg): a pre-S1-specific T cell response can bypass nonresponsiveness to the pre-S2 and S regions of HBsAg. J Immunol 137:315-322 (Pubitemid 16100306)
52. Bauer T, Weinberger K, Jilg W (2002) Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. Hepatology 35(2):455-465 (Pubitemid 34106389)
53. Milich DR (1999) Do T cells "see" the hepatitis B core and e antigens differently? Gastroenterology 116(3):765-768 (Pubitemid 29106783)
54. Weber B (2004) The diagnostic and clinical impact of the genetic variability of the S (surface) gene of hepatitis B virus. J Lab Med 28(1):56-69 (Pubitemid 38450791)
55. Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4(Suppl 1):11-20
56. Tian Y, Xu Y, Zhang Z, Meng Z, Qin L, Lu M, Yang D (2007) The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45(9):2971-2978 (Pubitemid 47417342)
57. Bruce SA, Murray K (1995) Mutations of some critical amino acid residues in the hepatitis B virus surface antigen. J Med Virol 46:157-161
58. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P (2000) Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60:113-121 (Pubitemid 30036785)
59. Locarnini S, Mcmillan J, Bartholomeusz A (2003) The hepatitis B virus and common mutants. Semin Liver Dis 23(1):5-20 (Pubitemid 36254659)
60. Weinberger KM, Bauer T, Böhm S, Jilg W (2000) High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81:1165-1174 (Pubitemid 30232700)
61. Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R (1995) Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 345:1406-1407
62. Zuckerman JN, Zuckerman AJ (2000) Current topics in hepatitis B. J Infect 41:130-136
63. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M (2004) Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab 50(3-4):159-162 (Pubitemid 38477539)
64. Coleman PF, Chen YC, Mushahwar IK (1999) Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24 (Pubitemid 29362160)
65. Weber B (2005) Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32:102-112 (Pubitemid 40093960)
66. Gibb R, Nimmo GR, O'Loughlin P, Lowe P, Drummond D (2007) Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection. J Med Virol 79:351-355 (Pubitemid 46355433)
67. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329 (Pubitemid 20264145)
68. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR (1994) A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 75:443-448 (Pubitemid 24050406)
69. Shields PL, Owsianka A, Carman WF, Boxall E, Hubscher SG, Shaw J, O'Donnell K, Elias E, Mutimer D (1999) Selection of hepatitis B surface "escape" mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function. Gut 45:306-309 (Pubitemid 29333784)
70. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S (1992) Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 32:264-268
71. Oon CJ, Chen WN, Goo KS, Goh KT (2000) Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. J Infect 41:260-264 (Pubitemid 32051047)
72. Wu L-M, Xu X, Zheng S-S (2005) Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective. Hepatobiliary Pancreat Dis Int 4(4):502-508 (Pubitemid 41723801)
73. Wang ZX, Ding G-S, Fu H, Zhang J-J, Chen X-S, Guo W-Y, Shi X-M, Fu Z-R (2004) Prevention of hepatitis B virus reinfection after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int 3(3):345-348 (Pubitemid 39173063)
74. Gerlich WH (2006) Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36(Suppl 1):S18-S22 (Pubitemid 44016153)
75. Lai M-W, Yeh C-S, Yeh C-T (2010) Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports. J Med Case Rep 4:190
76. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M (1994) Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68(4):2671-2676 (Pubitemid 24091946)
77. Song B-C, Kim S-H, Kim H, Ying Y-H, Kim H-J, Kim Y-J, Yoon J-H, Lee H-S, Cha C-Y, Kook Y-H, Kim B-J (2005) Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 76:194-202 (Pubitemid 40594003)
78. Lada O, Benhamou Y, Poynard T, Thibault V (2006) Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of 'a' determinant variants. J Virol 80(6):2968-2975 (Pubitemid 43346392)
79. Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C (1999) Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 180:1444-1451 (Pubitemid 29506444)
80. Chongsrisawat V, Thawornsuk N, Theamboonlers A, Louisirirotchanakul S, Poovorawan Y (2006) Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera. Viral Immunol 19(4):623-629 (Pubitemid 46068055)
81. Weinberger KM, Zoulek G, Bauer T, Böhm S, Jilg W (1999) A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 58:105-110 (Pubitemid 29226850)
82. Kreutz C (2002) Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 6(1):113-143 (Pubitemid 44133989)
83. Zhang JM, Xu Y, Wang XY, Yin YK, Wu XH, Weng XH, Lu M (2007) Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection. Clin Infect Dis 44(9):1161-1169 (Pubitemid 46651239)
84. Günther S, Fischer L, Pult I, Sterneck M, Will H (1999) Naturally occurring variants of hepatitis B virus. Adv Virus Res 52:25-137
85. Locarnini S (2004) Molecular virology of hepatitis B virus. Semin Liver Dis 24(Suppl 1):3-10 (Pubitemid 38738352)
86. Wang YM, Ng WC, Lo SK (1999) Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen. J Gastroenterol 34(5):600-606 (Pubitemid 29500324)
87. Beck J, Nassal M (2007) Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (Pubitemid 46165462)
88. Pawlotsky J-M (2005) The concept of hepatitis B virus mutant escape. J Clin Virol 34(Suppl 1):S125-S129 (Pubitemid 43197759)
89. Tabor E, Gerety RJ, Smallwood LA, Barker LF (1997) Coincident hepatitis B surface antigen and antibodies of different subtypes in human serum. J Immunol 118:369-370
90. Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C (2004) Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants. J Virol 78(16):8524-8535 (Pubitemid 39025118)
91. Peng XM, Huang GM, Li JG, Huang YS, Mei YY, Gao ZL (2005) High level of hepatitis B virus DNA after HBeAg-to-anti-HBe seroconversion is related to coexistence of mutations in its precore and basal core promoter. World J Gastroenterol 11(20):3131-3134
92. Miyakawa Y, Mizokami M (2003) Classifying hepatitis B virus genotypes. Intervirology 46(6):329-338 (Pubitemid 38037030)
93. Kidd-Ljunggren K, Miyakawa Y, Kidd AH (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83(Pt 6):1267-1280 (Pubitemid 34591320)
94. Schaefer S (2005) Hepatitis B virus: significance of genotypes. J Viral Hepat 12:111-124 (Pubitemid 40342168)
95. Kato H, Orito E, Gish RG, Bzowej N, Newsom M, Sugauchi F, Suzuki S, Ueda R, Miyakawa Y, Mizokami M. (2002) Hepatitis B 'e' antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology 35:922-929 (Pubitemid 34258388)
96. Magnius LO, Norder H (1995) Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24-35
97. Xu Z, Ren X, Liu Y, Li X, Bai S, Zhong Y, Wang L, Mao P, Wang H, Xin S, Wong VW, Chan HL, Zoulim F, Xu D (2011) Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure. J Gastroenterol 46(3):391-400
98. Kramvis A, Kew MC (1999) The core promoter of hepatitis B virus. J Viral Hepat 6(6):415-427
99. Yotsuyanagi H, Hino K, Tomita E, Toyoda J, Yasuda K, Iino S (2002) Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol 37:355-363 (Pubitemid 34969952)
100. Honigwachs J, Faktor O, Dikstein R, Shaul Y, Laub O (1989) Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer. J Virol 63(2):919-924 (Pubitemid 19057261)
101. López-Cabrera M, Letovsky J, Hu KQ, Siddiqui A (1991) Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183(2):825-829
102. Uchida T, Shimojima S, Gotoh K, Shikata T, Mima S (1994) Pathology of livers infected with "silent" hepatitis B virus mutant. Liver 14:251-256 (Pubitemid 24319994)
103. Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihara S, Chowdhury A, Tokuda A, Sakai S, Akagi S, Watanabe M, Fukumoto S (1996) Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-B, non-C chronic hepatitis. Microbiol Immunol 40:481-488 (Pubitemid 126481263)
104. Badur S, Akgün A (2001) Diagnosis of hepatitis B infections and monitoring of treatment. J Clin Virol 21:229-237 (Pubitemid 32496542)
105. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH (2012) Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology 55(1):68-76
106. Chan HL, Wong GL, Tse CH, Chan HY, Wong VW (2011) Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients. J Infect Dis 204(3):408-414
107. Yang PL, Althage A, Chung J, Maier H, Wieland S, Isogawa M, Chisari FV (2010) Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci U S A 107(2):798-802
108. Colomina-Rodríguez J, González-García D, Burgos-Teruel A, Fernández-Lorenz N, Guerrero-Espejo A (2005) Significado de la reactividad aislada anti-HBc como único marcador de infección de la hepatitis B. Enferm Infecc Microbiol Clin 23(2):80-85 (Pubitemid 40486605)
109. Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfeld KH, Löhr HF (1999) Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology 29(1):238-244 (Pubitemid 29024008)
110. Milich DR, Leroux-Roels GG (2003) Immunogenetics of the response to HBsAg vaccination. Autoimmun Rev 2(5):248-257 (Pubitemid 37083491)
111. Milich DR, Schödel F, Hughes JL, Jones JE, Peterson DL (1997) The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol 71(3):2192-2201 (Pubitemid 27078599)
112. Milich DR, McLachlan A, Thornton GB, Hughes JL (1987) Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329(6139):547-549 (Pubitemid 17124776)
113. Japhet MO, Adesina OA, Donbraye E, Adewumi MO (2011) Hepatitis B core IgM antibody (anti-HBcIgM) among hepatitis B surface antigen (HBsAg) negative blood donors in Nigeria. Virol J 8:513
114. Chen X, Shen Y, Xiang W (2011) Distribution characteristics of hepatitis B serological markers in hospitalized children and adolescents in Zhejiang, China between 2006 and 2010. Gut Liver 5(2):210-216
115. Wang YM, Ng WC, Kang JY, Yap I, Seet BL, Teo J, Smith R, Guan R (1996) Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs. Singapore Med J 37:150-152 (Pubitemid 126520866)
116. Mathet VL, Feld M, Espínola L, Sánchez DO, Ruiz V, Mandó O, Carballal G, Quarleri JF, D'Mello F, Howard CR, Oubiña J (2003) Hepatitis B virus S gene mutants in a patient with chronic active hepatitis with circulating anti-HBs antibodies. J Med Virol 69(1):18-26 (Pubitemid 35403649)
117. Zoulim F, Zhang X, Pichoud C, Trepo C (1996) Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc. J Hepatol 24(2):155-160 (Pubitemid 26059115)
118. Terada T, Moriyama M, Uchida T, Arakawa Y (2001) Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody. Intervirology 44(4):243-249 (Pubitemid 32757380)
119. Colson P, Borentain P, Motte A, Henry M, Moal V, Botta-Fridlund D, Tamalet C, Gérolami R (2007) Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers. Virology 367:30-40 (Pubitemid 47418929)
120. Kidd-Ljunggren K, Myhre E, Bläckberg J (2004) Clinical and serological variation between patients infected with different Hepatitis B virus genotypes. J Clin Microbiol 42(12):5837-5841 (Pubitemid 39664374)
121. Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK (2009) Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. J Med Virol 81(9):1531-1538
122. Hino K, Basuni AA, Ireland J, Newell A, Mphahlele J, Smit EJ, Ngui SL, Teo CG, Carman WF (2002) Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation? Dig Dis Sci 47(2):415-418 (Pubitemid 34124004)
123. Jongerius JM, Wester M, Cuypers HT, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF (1998) New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 38(1):56-59 (Pubitemid 28090941)
124. Lin C-L, Kao J-H (2011) The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 26(Suppl 1):123-130
125. Togashi H, Hashimoto C, Yokozawa J, Suzuki A, Sugahara K, Saito T, Yamaguchi I, Badawi H, Kainuma N, Aoyama M, Ohya H, Akatsuka T, Tanaka Y, Mizokami M, Kawata S (2008) What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? J Hepatol 49(1):17-24